Japan's Takeda Pharmaceutical is investing more than €100 million in a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.
The Latest
Marcon-based OrthoGeorgia became the first outpatient center in the state to perform a partial knee replacement using the MAKO system.
Technology has made ambulatory surgery in Oregon more efficient and effective as ever, with centers offering more procedures than they ever have before.
Despite falling revenues, Madison, N.J.-based Allergan's gastroenterology franchise grew by 8.2 percent in the third quarter, Market Realist reports.
Cambridge, Mass.-based Idera Pharmaceuticals and Bermuda-based Vivelix Pharmaceuticals entered into an exclusive license and collaboration agreement giving Vivelix the rights to develop and market IMO-9200, an antagonist of TLR 7,8 and 9, for non-malignant gastrointestinal disorders.
Michael Gilbert Goggins, MD, is a gastroenterologist and a professor of pathology, medicine and oncology at Baltimore's John Hopkins Medicine.
BMJ Quality and Safety published a survey finding most primary care physicians do not fully disclose essential information to patients regarding a potentially harmful medical error, News-Medical reported.
A Dallas-based Tenet Healthcare Corp. bond traded 0.3 percent lower on Nov. 28, 2016, according to Baseball News Source.
A recent Gallup poll found the majority of Americans want to either change or replace the ACA.
Atlanta-based Perimeter Center for Outpatient Surgery submitted form D for $206,000 equity financing, according to Frisco Fastball.
